Scleroderma - new aspects in pathogenesis and treatment
- PMID:22424190
- DOI: 10.1016/j.berh.2012.01.011
Scleroderma - new aspects in pathogenesis and treatment
Abstract
Systemic sclerosis (SSc) is a multisystem disease with a variable clinical course and a poor prognosis corresponding to extent of microangiopathy and skin and internal organ fibrosis. Microvascular damage provokes immune cells to produce autoantibodies, pro-inflammatory and pro-fibrotic cytokines and chemokines. The hallmark of SSc is excessive collagen production by activated fibroblasts and myofibroblasts, and its accumulation in skin and internal organs. Better understanding of SSc pathogenesis resulted in the development of drugs, such as prostanoids, endothelin-1 and phosphodiesterase inhibitors, for treatment of pulmonary arterial hypertension and digital ulcers. The use of biological therapies and anti-fibrotic agents is under investigation. Stem cell transplantation seems to be promising in restarting the immune system to diminish fibrosis and restore microvasculature. Future research will be directed at genetic factors, diagnostic and prognostic markers for fibrosis and microangiopathy, and development of drugs directed to pathogenic key cells and mediators.
© 2012 Elsevier Ltd. All rights reserved.
Similar articles
- Pathogenic Roles of Autoantibodies and Aberrant Epigenetic Regulation of Immune and Connective Tissue Cells in the Tissue Fibrosis of Patients with Systemic Sclerosis.Tsai CY, Hsieh SC, Wu TH, Li KJ, Shen CY, Liao HT, Wu CH, Kuo YM, Lu CS, Yu CL.Tsai CY, et al.Int J Mol Sci. 2020 Apr 27;21(9):3069. doi: 10.3390/ijms21093069.Int J Mol Sci. 2020.PMID:32349208Free PMC article.Review.
- New pathogenic and therapeutic concepts in systemic sclerosis.Hügle T, Huigens CA, van Laar JM.Hügle T, et al.Arzneimittelforschung. 2009;59(12):615-24. doi: 10.1055/s-0031-1296449.Arzneimittelforschung. 2009.PMID:20108646Review.
- From microvasculature to fibroblasts: Contribution of anti-endothelial cell antibodies in systemic sclerosis.Corallo C, Franci B, Lucani B, Montella A, Chirico C, Gonnelli S, Nuti R, Giordano N.Corallo C, et al.Int J Immunopathol Pharmacol. 2015 Mar;28(1):93-103. doi: 10.1177/0394632015572750.Int J Immunopathol Pharmacol. 2015.PMID:25816411
- Treating skin and lung fibrosis in systemic sclerosis: a future filled with promise?Antic M, Distler JH, Distler O.Antic M, et al.Curr Opin Pharmacol. 2013 Jun;13(3):455-62. doi: 10.1016/j.coph.2013.05.016. Epub 2013 Jun 6.Curr Opin Pharmacol. 2013.PMID:23747024Review.
- Emerging diagnostic and therapeutic challenges for skin fibrosis in systemic sclerosis.Abraham D, Lescoat A, Stratton R.Abraham D, et al.Mol Aspects Med. 2024 Apr;96:101252. doi: 10.1016/j.mam.2024.101252. Epub 2024 Feb 6.Mol Aspects Med. 2024.PMID:38325132Review.
Cited by
- Endothelin Receptors Expressed by Immune Cells Are Involved in Modulation of Inflammation and in Fibrosis: Relevance to the Pathogenesis of Systemic Sclerosis.Elisa T, Antonio P, Giuseppe P, Alessandro B, Giuseppe A, Federico C, Marzia D, Ruggero B, Giacomo M, Andrea O, Daniela R, Mariaelisa R, Claudio L.Elisa T, et al.J Immunol Res. 2015;2015:147616. doi: 10.1155/2015/147616. Epub 2015 May 18.J Immunol Res. 2015.PMID:26090478Free PMC article.
- Analysis of complement biomarkers in systemic sclerosis indicates a distinct pattern in scleroderma renal crisis.Okrój M, Johansson M, Saxne T, Blom AM, Hesselstrand R.Okrój M, et al.Arthritis Res Ther. 2016 Nov 18;18(1):267. doi: 10.1186/s13075-016-1168-x.Arthritis Res Ther. 2016.PMID:27863511Free PMC article.
- Adenosine A2A receptor promotes collagen type III synthesis via β-catenin activation in human dermal fibroblasts.Shaikh G, Zhang J, Perez-Aso M, Mediero A, Cronstein B.Shaikh G, et al.Br J Pharmacol. 2016 Dec;173(23):3279-3291. doi: 10.1111/bph.13615. Epub 2016 Oct 4.Br J Pharmacol. 2016.PMID:27595240Free PMC article.
- Characteristics of patients with systemic sclerosis living in Qatar.Alam F, Abdulaziz HM, Ul Haq I, Mahdy SM, Mohammed Siam AR, Chandra P, Al Emadi S.Alam F, et al.Qatar Med J. 2019 Dec 24;2019(3):16. doi: 10.5339/qmj.2019.16. eCollection 2019.Qatar Med J. 2019.PMID:31903322Free PMC article.
- Periodontal health status in systemic sclerosis patients: Systematic review and meta-analysis.Sredojevic S, Colak D, Gaspersic R, Pavlov Dolijanovic S, Jakovljevic A, Nikolic-Jakoba N.Sredojevic S, et al.PLoS One. 2024 Feb 2;19(2):e0291078. doi: 10.1371/journal.pone.0291078. eCollection 2024.PLoS One. 2024.PMID:38306335Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical